These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 35458450)
1. Exercising the Sanger Sequencing Strategy for Variants Screening and Full-Length Genome of SARS-CoV-2 Virus during Alpha, Delta, and Omicron Outbreaks in Hiroshima. Ko K; Takahashi K; Nagashima S; E B; Ouoba S; Takafuta T; Fujii Y; Mimori M; Okada F; Kishita E; Ariyoshi K; Hussain MRA; Sugiyama A; Akita T; Kuwabara M; Tanaka J Viruses; 2022 Mar; 14(4):. PubMed ID: 35458450 [TBL] [Abstract][Full Text] [Related]
2. Mass Screening of SARS-CoV-2 Variants using Sanger Sequencing Strategy in Hiroshima, Japan. Ko K; Takahashi K; Nagashima S; E B; Ouoba S; Hussain MRA; Akita T; Sugiyama A; Sakaguchi T; Tahara H; Ohge H; Ohdan H; Kubo T; Ishikawa N; Takafuta T; Fujii Y; Mimori M; Okada F; Kishita E; Ariyoshi K; Kuwabara M; Tanaka J Sci Rep; 2022 Feb; 12(1):2419. PubMed ID: 35165301 [TBL] [Abstract][Full Text] [Related]
3. Despite low viral titer in saliva samples, Sanger-based SARS-CoV-2 spike gene sequencing is highly applicable for the variant identification. Ko K; Takahashi K; Ito N; Sugiyama A; Nagashima S; Miwata K; Kitahara Y; Okimoto M; Ouoba S; Akuffo GA; E B; Akita T; Takafuta T; Tanaka J BMC Med Genomics; 2023 Aug; 16(1):199. PubMed ID: 37620887 [TBL] [Abstract][Full Text] [Related]
4. Molecular characterization and the mutation pattern of SARS-CoV-2 during first and second wave outbreaks in Hiroshima, Japan. Ko K; Nagashima S; E B; Ouoba S; Akita T; Sugiyama A; Ohisa M; Sakaguchi T; Tahara H; Ohge H; Ohdan H; Kubo T; Kishita E; Kuwabara M; Takahashi K; Tanaka J PLoS One; 2021; 16(2):e0246383. PubMed ID: 33544733 [TBL] [Abstract][Full Text] [Related]
5. Receptor-Binding-Motif-Targeted Sanger Sequencing: a Quick and Cost-Effective Strategy for Molecular Surveillance of SARS-CoV-2 Variants. Chaki SP; Kahl-McDonagh MM; Neuman BW; Zuelke KA Microbiol Spectr; 2022 Jun; 10(3):e0066522. PubMed ID: 35638906 [TBL] [Abstract][Full Text] [Related]
6. Sequencing Using a Two-Step Strategy Reveals High Genetic Diversity in the S Gene of SARS-CoV-2 after a High-Transmission Period in Tunis, Tunisia. Fares W; Ghedira K; Gdoura M; Chouikha A; Haddad-Boubaker S; Khedhiri M; Ayouni K; Lamari A; Touzi H; Hammemi W; Medeb Z; Sadraoui A; Hogga N; Ben Alaya N; Triki H Microbiol Spectr; 2021 Dec; 9(3):e0063921. PubMed ID: 34756072 [TBL] [Abstract][Full Text] [Related]
7. Identification of Various Recombinants in a Patient Coinfected With the Different SARS-CoV-2 Variants. Sayama Y; Sakagami A; Okamoto M; Sakamoto M; Koizumi H; Kimura Y; Dapat C; Saito M; Suzuki Y; Sasaki M; Sugawara N; Oshitani H Influenza Other Respir Viruses; 2024 Jun; 18(6):e13340. PubMed ID: 38890805 [TBL] [Abstract][Full Text] [Related]
8. A comprehensive genomic study, mutation screening, phylogenetic and statistical analysis of SARS-CoV-2 and its variant omicron among different countries. Ahmad SU; Hafeez Kiani B; Abrar M; Jan Z; Zafar I; Ali Y; Alanazi AM; Malik A; Rather MA; Ahmad A; Khan AA J Infect Public Health; 2022 Aug; 15(8):878-891. PubMed ID: 35839568 [TBL] [Abstract][Full Text] [Related]
10. Partial spike gene sequencing for the identification of SARS-CoV-2 variants circulating in Cameroon in 2021. Monamele CG; Sadeuh-Mba SA; Ilouga PV; Moumbeket MHY; Messanga LLE; Mounchili Njifon A; Madaha EL; Njankouo RM; Tagnouokam-Ngoupo PA; Tchatchueng JBM; Tejiokem MC; Perraut R; Eyangoh S; Njouom R J Infect Dev Ctries; 2024 May; 18(5):701-709. PubMed ID: 38865404 [TBL] [Abstract][Full Text] [Related]
11. SARS-CoV-2 Variants Identification; A Fast and Affordable Strategy Based on Partial S-Gene Targeted PCR Sequencing. Martínez-Murcia A; Garcia-Sirera A; Navarro A; Pérez L Viruses; 2022 Nov; 14(11):. PubMed ID: 36423197 [TBL] [Abstract][Full Text] [Related]
12. Validation of a new strategy for the identification of SARS-CoV-2 variants by sequencing the spike gene by Sanger. Murillo E; Palacio-Rua K; Afanador-Ayala C; García-Correa JF; Zuluaga AF Enferm Infecc Microbiol Clin (Engl Ed); 2023 May; 41(5):284-289. PubMed ID: 37144832 [TBL] [Abstract][Full Text] [Related]
13. Implementation of an In-House Platform for Rapid Screening of SARS-CoV-2 Genome Variations. Zare Ashrafi F; Mohseni M; Beheshtian M; Fattahi Z; Ghodratpour F; Keshavarzi F; Behravan H; Kalhor M; Jalalvand K; Azad M; Koshki M; Jafarpour A; Ghaziasadi A; Abdollahi A; Kiani SJ; Ataei-Pirkooh A; Rezaei Azhar I; Bokharaei-Salim F; Haghshenas MR; Babamahmoodi F; Mokhames Z; Soleimani A; Ziaee M; Javanmard D; Ghafari S; Ezani A; Ansari Moghaddam A; Shahraki-Sanavi F; Hashemi Shahri SM; Azaran A; Yousefi F; Moattari A; Moghadami M; Fakhim H; Ataei B; Nasri E; Poortahmasebi V; Varshochi M; Mojtahedi A; Jalilian F; Khazeni M; Moradi A; Tabarraei A; Piroozmand A; Yahyapour Y; Bayani M; Aboofazeli A; Ghafari P; Keramat F; Tavakoli M; Jalali T; Pouriayevali MH; Salehi-Vaziri M; Khorram Khorshid HR; Najafipour R; Malekzadeh R; Kahrizi K; Jazayeri SM; Najmabadi H Arch Iran Med; 2023 Feb; 26(2):69-75. PubMed ID: 37543926 [TBL] [Abstract][Full Text] [Related]
14. Mutation Analysis of SARS-CoV-2 Variants Isolated from Symptomatic Cases from Andhra Pradesh, India. Nagaraja M; Sireesha K; Srikar A; Sudheer Kumar K; Mohan A; Vengamma B; Tirumala C; Verma A; Kalawat U Viruses; 2023 Jul; 15(8):. PubMed ID: 37631999 [TBL] [Abstract][Full Text] [Related]
15. Developing an Amplification Refractory Mutation System-Quantitative Reverse Transcription-PCR Assay for Rapid and Sensitive Screening of SARS-CoV-2 Variants of Concern. Xiong D; Zhang X; Shi M; Wang N; He P; Dong Z; Zhong J; Luo J; Wang Y; Yu J; Wei H Microbiol Spectr; 2022 Feb; 10(1):e0143821. PubMed ID: 34985323 [TBL] [Abstract][Full Text] [Related]
16. Whole genome amplicon sequencing and phylogenetic analysis of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from lineage B.1.36.27 isolated in Hong Kong. Tsang HF; Yu ACS; Wong HT; Leung WMS; Chiou J; Wong YKE; Yim AKY; Tsang DNC; Tsang AK; Wong WT; Wong SCC; Cho WCS Expert Rev Mol Diagn; 2022 Jan; 22(1):119-124. PubMed ID: 34878349 [TBL] [Abstract][Full Text] [Related]